Viewing Study NCT05637112


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-02-28 @ 10:55 AM
Study NCT ID: NCT05637112
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module